Cytogenetic features at baseline
| IPSS prognostic group . | No. (%) . |
|---|---|
| No. patients | 214 (100) |
| Good | 177 (83) |
| Normal karyotype | 160 |
| −Y | 10 |
| Deletion 20q | 6 |
| +X | 1 |
| Intermediate | 27 (13) |
| Trisomy 8 | 11 |
| Deletion 13q | 3 |
| Trisomy 19 | 2 |
| Deletion 11q | 2 |
| Trisomy 15 | 1 |
| Deletion 17p | 1 |
| i14q | 1 |
| Add 11q | 1 |
| Deletion 20q and add 20p | 1 |
| t(1;12) | 1 |
| t(2;8) | 1 |
| t(2;3) | 1 |
| t(2;11) | 1 |
| Poor | 3 (1) |
| Deletion 7q | 2 |
| Complex | 1 |
| Missing | 7 (3) |
| IPSS prognostic group . | No. (%) . |
|---|---|
| No. patients | 214 (100) |
| Good | 177 (83) |
| Normal karyotype | 160 |
| −Y | 10 |
| Deletion 20q | 6 |
| +X | 1 |
| Intermediate | 27 (13) |
| Trisomy 8 | 11 |
| Deletion 13q | 3 |
| Trisomy 19 | 2 |
| Deletion 11q | 2 |
| Trisomy 15 | 1 |
| Deletion 17p | 1 |
| i14q | 1 |
| Add 11q | 1 |
| Deletion 20q and add 20p | 1 |
| t(1;12) | 1 |
| t(2;8) | 1 |
| t(2;3) | 1 |
| t(2;11) | 1 |
| Poor | 3 (1) |
| Deletion 7q | 2 |
| Complex | 1 |
| Missing | 7 (3) |